Skip to main content
Log in

Biotechnology Trade with Japan

  • Technology Report
  • Published:
Bio/Technology Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Pharmaceutical Administration in Japan, 2nd ed. Pharmaceutical Affairs Bureau, Ministry of Health and Welfare of Japan, Tokyo. February 1980.

  2. Commercial Biotechnology: An International Analysis. U.S. Congress Office of Technology Assessment, OTA-BA218, Washington D.C. January 1984.

  3. Yakuji Handobukku 1983 (Drug Industry Handbook 1983). Yakugyo Jiho Co., Tokyo, p. 21–23.

  4. Nihon Shoken Shimbun. 1982. Jisei-dai no Shinyaku Kaihatsu to Kanren Kigyo (Next generation drug development and related firms). Nihon Shoken Shimbunsha, Tokyo.

  5. Lohr, S . 1983. Merck's big venture in Japan. N.Y. Times, New York. 13 October 1983.

  6. Anon. 1984. CIBA-Geigy Japan dropping marketing deals. Japan Economic J. 22: 15.

  7. Handling of foreign test data and Japanese GLP 1982. Pharmaceutical Affairs Bureau, Ministry of Health and Welfare of Japan. Yakugyo Jiho Co., Tokyo. 1982.

  8. Measures Taken by the Japanese Ministry of Health and Welfare (MHW) for Further Opening the Japanese Market Regarding Pharmaceuticals, Food, and So Forth. Ministry of Health and Welfare of Japan, Tokyo. April 1983.

  9. Government to approve imports of viral hepatitis vaccine. Japan Times, Tokyo. 29 May 1983.

  10. Ministry of Health and Welfare to allow import of hepatitis vaccine. Tokyo Shimbun, Tokyo. 29 May 1983.

  11. Anon. 1984. B hepatitis vaccine project. Japan Economic J. 22: 16.

Download references

Author information

Author notes

  1. Amelia Porges is an assistant general counsel in the Office of the U.S. Trade Representative, Executive Office of the President, Washington, D.C. 20506. The views and opinions expressed herein are solely those of the author and do not necessarily reflect the views and policies of the Office of the U.S. Trade Representative or the U.S. government.

    • Amelia Porges
Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Porges, A. Biotechnology Trade with Japan. Nat Biotechnol 2, 327–332 (1984). https://doi.org/10.1038/nbt0484-327

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0484-327

  • Springer Nature America, Inc.

Navigation